We would love to hear your thoughts about our site and services, please take our survey here.
Https://www.ispreview.co.uk/index.php/2023/08/cable-hungry-rats-knock-out-openreach-broadband-in-tring.html
I was unfortunate enough to live within the area covered by this outage. No internet from Sunday Evening to Tuesday afternoon.
If rats find fibre cable particularly tasty it might be too early to say BT maintenance charges will decrease drastically once we have full fibre?
Has anyone had their ROC re-invested by their broker?
I'm with ii who paid out last Friday but don't appear to have re-invested the dividend automatically although it is on my dividend reinvestment list.
Looks like it isn't treated as a dividend in this respect.
This looks to me way overpriced effectively paying £6 per dose. You could probably get at least 2 doses of viagra or 4 of sildenafil (generic viagra) for that price.
When you're effectively buying the equivalent of hand sanitiser (as pointed out in some of comments on the media reviews) this looks like a rip off.
Thanks to all the people who replied on my issues with IWEB.
I've had issues before with certain stocks on IWEB but albeit they don't have many bells and whistles I find them pretty cheap to run with no additional charges and reasonable trading costs
DEC is still one of my best dividend payers even with the 30% charge but since my wife has an II account I may just sell from IWEB and buy on ii.
HI - I'm new to this share and I've just received my first dividend and I too have been taxed at 30%.
I queried this with my broker, IWEB, and explained that I had filled out a W8BEN form for my account some months earlier.
They say this is irrelevant and that because it is a registered in the UK although a US company that the 30% is corrrect and is what is paid out by Crest.
I pointed out what I've read on here that others have been paying 15% but he claims there is nothing I can do to reduce this.
Anyone else on IWEB or can explain what I need to do to get the 15% rate?
Some positive reporting on PRTC in todays Financial Times;
BUY: PureTech (PRTC) A share price recovery has restored PureTech’s lustre, while the subsidiaries are still pouring out cash, writes Julian Hofmann. Biotech investors seem to have discovered some of their appetite for risk over the past few months — the biotech sector, generally, was one of the first to de-rate in advance of the technology collapse. However, the market seems to be tentatively looking for value in biotechnology, the net result of which is that PureTech can sit out the long wait for its clinical results with a degree of confidence in its equity and funding position. The company’s sprawling drug pipeline encompasses everything from irritable bowel syndrome to oncology medicines to treat solid state tumours. Meaningful data readouts won’t be before the end of 2023, so investors merely need to sit on their positions and wait for something to happen. The positive is that PureTech is still attracting both equity investments into its subsidiaries, more than $113mn (£95.7mn) in the half, while post-period the company received $115mn from share sales in its Karuna subsidiary. In total, the Karuna initial investment of $18.5mn has now returned an astonishing $681mn for PureTech. In addition, another subsidiary Akili, listed on Nasdaq, raised a further $164mn. The increase in liquidity also made it easier for management to announce a $50mn share buyback alongside these results. PureTech sits on plentiful cash reserves and has a clear runway to develop meaningful data next year as its internal development pipeline is now fully funded by its subsidiary businesses. With losses predicted for some time yet, a meaningful valuation is awkward, but broker Peel Hunt believes the cash generated from its spinout companies alone covers the current share price.
Is anyone else having problems finding GlaxoSmithKline on Google Finance. If I type in glaxo or GSK all I get is NYSE and a few other foreign exchanges but not LSE.
Similarily I use the GoogleFinance app on Google Sheets and that just returns N/A.
I'm using the ticker LON:GSK.
TILS shares now showing on my ii account.
Anyone know if you can get the price displayed in GBP rather than dollars?
My shares with IWEB have also been moved to my share dealing account.
I queried this with them and they said the shares were no longer considered compatible with an ISA account!
My wife has shares with ii and these are still shown under an ISA.
On the face of it, losing a chairman like Jan Du Plessis is a major blow to BT. Diminutive he might be, but the South African comes with a big, tough reputation - more bulldog than chihuahua - and is a veteran of multiple top-level boardrooms.
Yet, it seems he may have been more bark than bite when it came to forcing through change at BT. Du Plessis blamed the demands of decades at the top for his decision to step down prematurely.
That said, rumours of a rift with boss Philip Jansen over the pace of the company’s restructuring are longstanding.
The chairman’s priority was improving relations with the regulator but Jansen favoured an unflinching overhaul including the possible sale of a stake in BT’s Openreach arm.
Du Plessis’s exit is certainly badly timed. A crucial and long-awaited Ofcom decision on fibre wholesale pricing is due later this month.
Now Sky News reports that Jansen threatened to go unless Du Plessis was replaced. Chairman and chief executives clash all the time but this suggests the relationship had broken down completely, at a crucial time in BT’s turnaround too.
Perhaps his exit will accelerate transformation in the way Jansen hopes. Thousands of cuts have been made but more are needed and although the chief executive is desperate to crack on, BT is a notoriously sclerotic beast.
Decades after privatisation, the bureaucracy of state ownership still festers, making decision-making painfully slow. The tendency inside BT is to wait for the government or regulator to force decisions upon it, rather than tackling problems head on.
Ultimately though, Jansen may live to regret his coup. His planned shake-up is high-risk and will win few friends. Selling a stake in Openreach to private equity just as the government pushes ahead with plans for a nationwide broadband rollout would be highly contentious.
And the value destruction of the last few years has been shocking: a 70pc fall in the share price in five years has left BT with a stockmarket value of not much more than the £12.5bn it forked out on mobile operator EE in 2016.
With Du Plessis gone, the pressure on his adversary to deliver will be even more intense.
I certainly hope so. I'm in the same boat just moved to ii from Share Centre. I have another account with IWEB and they actually have listed the Accustem shares on my portfolio albeit with no value attached.
I intend to take it up with them if and when we hear that others have received their shares.
I certainly hope so. I'm in the same boat just moved to ii from Share Centre. I have another account with IWEB and they actually have listed the Accustem shares on my portfolio albeit with no value attached.
I intend to take it up with them if and when we hear that others have received their shares.
Just to add to BT's problems at the moment the Telegraph is reporting that the trial following the BT Italia accounting scandal is due to start on Tuesday. They're predicting impact on BT for 'years to come'.
Seems a little OTT but the original crisis seemed incredibly overblown to me and the impact on BT was out of all proportion to the fraud perpetrated.
I won't link to it since it's behind a paywall but the headline reads;
'Day of reckoning looms for the bosses of BT’s stricken Italian arm
The trial into accounting irregularities at BT Italia is opening at last and could cast a shadow over the telecoms giant for years to come
https://www.theguardian.com/technology/2020/may/22/boris-johnson-forced-to-reduce-huaweis-role-in-uks-5g-networks
Boris Johnson has backed away from his initial stance on Huawei to bow to pressure from the US and his own backbenchers.
Likely to be even more cost and delay to 5G rollout for BT and other mobile network suppliers.
Article in ISP Review on likely impact;
Leaving aside the inevitable ramifications of becoming less open to inward investment from China. Any dramatic change of course now seems likely to produce a hostile response from the industry, which will have already revised their plans to adopt the Government’s earlier balanced approach (BT alone is set to take a £500m hit from that). But completely removing Huawei’s kit from UK networks by 2023 also seems like an unworkable ask.
Firstly, part of the reason for the Government’s decision in January was likely to be because completely banning Huawei could make the rollout of new “gigabit-capable” 5G, and possibly also fixed broadband ISP networks, both much slower and more expensive to achieve. This in turn would have impacted Boris’s recent £5bn pledge to ensure that every UK home can access 1Gbps speed broadband networks by the end of 2025.
The notion of reducing Huawei’s involvement to “zero” by 2023 is also unrealistic for other reasons, not least because it would mean ripping out masses of existing 4G, and some newer 5G, mobile kit, as well as replacing tens of thousands of Huawei based broadband street cabinets (FTTC / VDSL2) and ripping their “full fibre” (FTTP) Optical Network Terminals (ONT) off the walls in UK homes etc.
Achieving that kind of mass infrastructure cull by 2023 would be a massive task and could well cost billions across all of the various network operators (i.e. who pays and is it right to expect operators to foot such a colossal bill, despite being given the all clear for years beforehand?). All of this would also divert engineers and resources from deploying new services, possibly for several years, which will dramatically slow the 5G and FTTP roll-out.
https://www.ispreview.co.uk/index.php/2020/05/government-considers-zero-huawei-kit-in-uk-telecoms-by-2023.
Anyone else here use Yahoo Finance.
I have set up a Portfolio on Yahoo Finance using my BTInternet email to login.
However with the changes made today by BT on Email I can't seem to sign in.
Anyone else in the same boat? Even better anyone any idea how I can get back my portfolio?
I'm not sure there is any advantage in asking HL to transfer cash out of your 212 account. Whether you do it or HL do it it will take a few days to transfer.
You can ask HL to transfer the shares without selling them. There's probably an online form or you may be able to contact their helpdesk. That way you won't lose out on any gains made in the few days it will take to transfer the cash.
From the LEX column in today's FT
"All this bad news leaves shareholders stranded by the side of the road. Suspension of both the dividend and profit guidance by such a conservative group reinforces the feeling that BT is at best a cheaply valued dead end for investors."
I almost decided to buy more since the price is ridiculously low for a company making a profit of £2.4 billion a year then I remembered the many times I've done this in the past and been immediately shocked to find its gone lower.
Never again.
Interesting article in the Telegraph about the (mis?) use of ventilators in treatment of ARDS - its one of the few not on premium so I think readable without subscription;
https://www.telegraph.co.uk/global-health/science-and-disease/intensive-care-doctors-question-overly-aggressive-use-ventilators/
The implication here is that they are treating patients as if they are suffering from ARDS but Covid 19 is not presenting in that fashion and the use of aggressive ventilation is not the best treatment.
“The initial message was treat as if you were treating for acute respiratory distress syndrome (ARDS) with a high PEEP,” said Daniels. “But now we are becoming braver. We are tolerating much lower blood oxygen levels and using lower pressures. We are learning as we go along”.
Could this have an impact on the trials of Traumakine in that its not the right drug for treating COVID 19? This doesn't change the value of FARON overall but it might mean that the people who've invested here because of its association as a treatment for the virus may drop this like a stone if it has no impact for patients with that problem.
I didn't get my dividend for TRIG though NESF (which has the same Payment Date) paid out today.
BT has announced that its Chief Execuive Philip Jansen has contracted coronavirus.
Here’s a statement from the company:
“Philip Jansen, Chief Executive, BT Group has late this afternoon tested positive for COVID-19 and as a result has followed the Public Health England protocols to self-isolate.
BT is now working closely with Public Health England to undertake a full deep clean of relevant parts of its Group headquarters and will ensure those employees who have had contact with Philip are appropriately advised.
Philip Jansen said: “Having felt slightly unwell I decided as a precaution to be tested. As soon as the test results were known I isolated myself at home.”
“I’ve met several industry partners this week so felt it was the responsible thing to do to alert them to this fact as soon as I could.”
“Given my symptoms seem relatively mild, I will continue to lead BT but work with my team remotely over the coming week. There will be no disruption to the business.”